Resources

We are pleased to share this comprehensive new resource designed to support meaningful conversations between healthcare providers, patients, and their care partners.

This infographic will provide clear, actionable insights and practical tips into recognizing, monitoring, and addressing these side effects. This guide is intended to empower patients and caregivers with the knowledge to proactively address side effects while collaborating closely with their healthcare teams through the treatment journey.

We are excited to share with you Bispecific Agents in Solid Tumors: Nurse Resource Guide, developed by nurse experts particularly for nursing and other medical professions. This guide will serve as a valuable resource for effectively implementing the use of bispecific agents for solid tumors in healthcare practice, including guidance on monitoring and managing adverse events.

The Navigator Guide: Walking With a Patient Down the Early Breast Cancer Path is a resource that oncology nurses and navigators can use to assist patients and caregivers in the fight against early-stage breast cancer. Oncology nurses and navigators guide patients through their treatment journey from time of diagnosis into survivorship, providing education, resources, and support.

The Academy of Oncology Nurse & Patient Navigators, with support from TerSera Therapeutics, is delighted to offer you a resource to assist with educating your premenopausal patients with estrogen receptor-positive metastatic breast cancer and their caregivers as they navigate through the treatment journey, including managing the effects of ovarian function suppression drug therapy.

AONN+, with support from Gilead Sciences, is delighted to introduce you to a resource to support in educating your patients and caregivers in understanding the journey through Myelodysplastic Syndromes (MDS).

In partnership with Daiichi Sankyo, this roadmap is intended to provide a comprehensive overview and educational resource for advanced practice providers (Nurse Practitioner, Pharmacist, Physician Assistant) and oncology nurse navigators on HER2+/HER2-low breast cancer including key considerations for treatment, setting upfront expectations, and adverse event management.

AONN+, with support from TerSera Therapeutics, is thrilled to introduce you to a resource to assist you in educating your patients and caregivers in understanding the estrogen receptor–positive, premenopausal breast cancer journey.